Yorvipath 168 μg/0.56 ml
Yorvipath 168 μg/0.56 ml is a medicine authorised by Swissmedic under authorisation number 69889. The authorisation holder is Ascendis Pharma Switzerland GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 09 December 2025 and the authorisation is limited until 08 December 2030. ATC code H05AA05 places the medicine in the group Calcium homeostasis.
| Authorisation number | 69889 |
|---|---|
| Name | Yorvipath 168 μg/0.56 ml |
| Full name | Yorvipath 168 μg/0.56 ml, Injektionslösung im Fertigpen |
| Authorisation holder | Ascendis Pharma Switzerland GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | H05AA05 |
| First authorisation | 09 December 2025 |
| Authorisation validity | 08 December 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Yorvipath 168 μg/0.56 ml, Injektionslösung im Fertigpen | B | 09 December 2025 |
| 2 | Yorvipath 294 μg/0.98 ml, Injektionslösung im Fertigpen | B | 09 December 2025 |
| 3 | Yorvipath 420 μg/1.4 ml, Injektionslösung im Fertigpen | B | 09 December 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 2 x 1 | Injektor(en), vorgefüllt/Pen | H05AA05 | 07.99.0. | B |
| 4 | 2 | Injektor(en), vorgefüllt/Pen | H05AA05 | 07.99.0. | B |
| 2 | 2 x 1 | Injektor(en), vorgefüllt/Pen | H05AA05 | 07.99.0. | B |
| 5 | 2 | Injektor(en), vorgefüllt/Pen | H05AA05 | 07.99.0. | B |
| 3 | 2 x 1 | Injektor(en), vorgefüllt/Pen | H05AA05 | 07.99.0. | B |
| 6 | 2 | Injektor(en), vorgefüllt/Pen | H05AA05 | 07.99.0. | B |
Scroll the table sideways
Frequently asked questions
Is Yorvipath 168 μg/0.56 ml authorised in Switzerland?
Yes. Yorvipath 168 μg/0.56 ml is authorised by Swissmedic under authorisation number 69889, data as of 01 September 2026. The authorisation is limited until 08 December 2030.
Which dispensing category does Yorvipath 168 μg/0.56 ml have?
Yorvipath 168 μg/0.56 ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Yorvipath 168 μg/0.56 ml?
The authorisation holder is Ascendis Pharma Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.